Dr. Zhao Lijun, head of the R&D department of our company, gave a detailed introduction to Shenzhen Cell Valley, covering the company's strategic planning, recent development trends and scientific research projects. Shenzhen Cell Valley, as one of the many biomedical enterprises in Pingshan District, has been committed to research and development in the field of cell and gene therapy and cell therapy since its establishment. So far, from the construction of viral vector pipeline to cell product pipeline, and then cover the IIT/IND/NDA auxiliary application process, and expand to the industry talent cultivation, has built a comprehensive, integrated entrusted service system.

The presentation came to a close with discussions and exchanges among leaders, guests, experts in the biomedical field and entrepreneurs. By participating in this promotion activity, the exchange platform of cutting-edge science and technology in the tumor immunotherapy industry has been effectively built, and the deepening development of interdisciplinary cooperation among enterprises has been further promoted.